Abstract |
An effective therapy for human adenovirus (HAdV) infections in immunocompromised patients and healthy individuals with community-acquired pneumonia remains an unmet medical need. We herein reported a series of novel substituted N-(4-amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide analogues as potent HAdV inhibitors. Compounds 6, 15, 29, 40, 43, 46, 47, and 54 exhibited increased selectivity indexes (SI > 100) compared to the lead compound niclosamide, while maintaining sub-micromolar to low micromolar potency against HAdV. The preliminary mechanistic studies indicated that compounds 6 and 43 possibly target the HAdV DNA replication process, while compounds 46 and 47 suppress later steps of HAdV life cycle. Notably, among these derivatives, compound 15 showed improved anti-HAdV activity (IC50 = 0.27 μM), significantly decreased cytotoxicity (CC50 = 156.8 μM), and low in vivo toxicity (maximum tolerated dose = 150 mg/kg in hamster) as compared with niclosamide, supporting its further in vivo efficacy studies for the treatment of HAdV infections.
|
Authors | Jimin Xu, Judith Berastegui-Cabrera, Na Ye, Marta Carretero-Ledesma, Jerónimo Pachón-Díaz, Haiying Chen, Maria Eugenia Pachón-Ibáñez, Javier Sánchez-Céspedes, Jia Zhou |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 63
Issue 21
Pg. 12830-12852
(11 12 2020)
ISSN: 1520-4804 [Electronic] United States |
PMID | 33112138
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- 5-chloro-2-hydroxybenzamide
- Antiviral Agents
- Benzamides
|
Topics |
- Adenoviruses, Human
(drug effects, physiology)
- Animals
- Antiviral Agents
(chemical synthesis, chemistry, pharmacology)
- Benzamides
(chemistry, pharmacology)
- Cell Line, Tumor
- Cell Survival
(drug effects)
- Cricetinae
- Drug Evaluation, Preclinical
- Humans
- Lethal Dose 50
- Structure-Activity Relationship
- Virus Internalization
(drug effects)
- Virus Replication
(drug effects)
|